|
Oct 9
|
Reneo Pharmaceuticals: Navigating Financial Challenges and Corporate Changes
|
|
Oct 7
|
OnKure and Reneo Pharmaceuticals complete merger
|
|
Oct 4
|
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
|
|
May 13
|
Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
|
|
May 13
|
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
|
|
May 7
|
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
|
|
Mar 28
|
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
|
|
Mar 25
|
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
|
|
Dec 21
|
These Stocks under $10 Are Poised To Explode
|
|
Oct 25
|
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
|
|
Oct 20
|
12 Best Performing Biotech Stocks in 2023
|
|
Sep 20
|
Reneo Pharmaceuticals (NASDAQ:RPHM) Is In A Good Position To Deliver On Growth Plans
|
|
Aug 10
|
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
|
|
Aug 10
|
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) stock price dropped 10% last week; private equity firms would not be happy
|